Patent details
EP2477985 Title: CRLX101 FOR USE IN THE TREATMENT OF CANCER
Basic Information
- Publication number:
- EP2477985
- PCT Application Number:
- US2010048973
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP108177841
- PCT Publication Number:
- WO2011034954
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CRLX101 FOR USE IN THE TREATMENT OF CANCER
- French Title of Invention:
- CRLX101 POUR SON UTILISATION DANS LE TRAITEMENT DU CANCER
- German Title of Invention:
- CRLX101 ZUR VERWENDUNG BEI DER KREBSBEHANDLUNG
- SPC Number:
Dates
- Filing date:
- 15/09/2010
- Grant date:
- 07/11/2018
- EP Publication Date:
- 25/07/2012
- PCT Publication Date:
- 24/03/2011
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/11/2018
- EP B1 Publication Date:
- 07/11/2018
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 15/09/2019
- Expiration date:
- 15/09/2030
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 31/10/2018
- Name:
- BlueLink Pharmaceuticals, Inc.
- Address:
- 2503 S. Loop Drive, Ste 5100, Ames, Iowa 50010, United States (US)
Inventor
1
- Name:
- DAVIS, Mark
- Address:
- United States (US)
2
- Name:
- SCHLUEP, Thomas
- Address:
- United States (US)
3
- Name:
- RYAN, John
- Address:
- United States (US)
4
- Name:
- OLIVER, James, C.
- Address:
- United States (US)
5
- Name:
- YEN, Yun
- Address:
- United States (US)
Priority
1
- Priority Number:
- 242752 P
- Priority Date:
- 15/09/2009
- Priority Country:
- United States (US)
2
- Priority Number:
- 317039 P
- Priority Date:
- 24/03/2010
- Priority Country:
- United States (US)
3
- Priority Number:
- 332150 P
- Priority Date:
- 06/05/2010
- Priority Country:
- United States (US)
4
- Priority Number:
- 381851 P
- Priority Date:
- 10/09/2010
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/724; A61P 35/00; A61K 47/61;
Publication
European Patent Bulletin
- Issue number:
- 201845
- Publication date:
- 07/11/2018
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|